Viking Therapeutics (VKTX) is identified by Oppenheimer among five potential biotech M&A candidates ahead of J.P. Morgan Healthcare Conference. Read more here.
I suspected most financial assets were in 401(k) plans and most 401(k) holdings were directed by target-date funds, but the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback